
Krystal Biotech, Inc.
KRYS·NASDAQ
Last updated as of 2026-04-13 16:29 EST. Stock price information is sourced from TradingView and reflects real-time market prices.
Insights
Calculator
News
KRYS stock price change
On the last trading day, KRYS stock closed at 259.00 USD, with a price change of 0.26% for the day.
Trade stock perpsTrending stocks
About Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn moreKRYS key data
Previous close259.00 USD
Market cap7.57B USD
Volume162.52K
P/E ratio37.84
Dividend yield (TTM)0.00%
Dividend amount-
Last ex-dividend date-
Last payment date-
EPS diluted (TTM)6.84 USD
Net income (FY)204.83M USD
Revenue (FY)389.13M USD
Next report dateMay 11, 2026
EPS estimate1.500 USD
Revenue estimate112.09M USD USD
Shares float25.33M
Beta (1Y)0.37

Krystal Biotech, Inc. overview
Krystal Biotech, Inc. operates as a biotechnology company, which engages in discovery, development, manufacturing, and commercialization of pharmaceutical products. It offers the product, VYJUVEK. The company was founded by Krish S. Krishnan and Suma M. Krishnan on April 15, 2016 and is headquartered in Pittsburgh, PA.
Sector
Health technology
Industry
Biotechnology
CEO
Krish S. Krishnan
Headquarters
Pittsburgh
Website
krystalbio.com
Founded
2016
Employees (FY)
295
Change (1Y)
+20 +7.27%
Revenue / Employee (1Y)
1.32M USD
Net income / Employee (1Y)
694.34K USD
KRYS stock price forecast
According to technical indicators for KRYS stock, the price is likely to fluctuate within the range of 260.57–350.77 USD over the next week. Market analysts predict that the price of KRYS stock will likely fluctuate within the range of 245.00–389.02 USD over the next months.
Based on 1-year price forecasts from 51 analysts, the highest estimate is 446.39 USD, while the lowest estimate is 254.22 USD.
For more information, please see the
KRYS stock price forecast
page.
Latest KRYS stock news
onsemi to Host Financial Analyst Day
Finviz2026-02-24 21:18:10
Guggenheim Lifts PT on Krystal Biotech (KRYS) to $284 From $224
Finviz2026-02-28 07:24:45
Exclusive-Anthropic investors push to de-escalate Pentagon clash over AI safeguards, sources say
101 finance2026-03-04 17:06:10
Exclusive-Anthropic investors push to de-escalate Pentagon clash over AI safeguards, sources say
101 finance2026-03-04 17:09:42
AI startup Thinking Machines clinches capital and a major chip supply deal from Nvidia
101 finance2026-03-10 13:12:47
AI startup Thinking Machines clinches capital and a major chip supply deal from Nvidia
101 finance2026-03-10 13:15:18
Key Information on This Obesity Drug Maker That Recently Secured a Fresh $7 Million Funding
101 finance2026-03-16 20:27:48
This biotechnology company, which has developed a promising new MS treatment, secures an $8 million investment despite a 30% decline in its share price.
101 finance2026-03-16 20:27:46
Why has Krystal Biotech (KRYS) dropped 11.5% following its most recent earnings announcement?
101 finance2026-03-19 16:34:02
Ocugen Stock Forecast: Weighing Cash Usage Against Advanced Trial Results
101 finance2026-03-20 13:03:54
Ocugen Stock Forecast: Weighing Cash Usage Against Advanced Trial Results
101 finance2026-03-20 13:03:54
ACT Capital's Unconventional Move: Acquiring TG Therapeutics Shares at a Value Gap Despite 30% Doubt
101 finance2026-03-21 22:45:45
Exclusive-OpenAI sweetens private equity pitch amid enterprise turf war with Anthropic, sources say
101 finance2026-03-23 10:09:34
Palvella Therapeutics Strengthens Leadership Team with Appointment of Rare Disease Commercial Leader Jennifer J. McDonough as Senior Vice President of Market Access and Patient Services
Finviz2026-03-23 11:33:56
Palvella Therapeutics Reports Full Year 2025 Financial Results and Provides Corporate Update
Finviz2026-03-31 11:33:51
onsemi to Host Financial Analyst Day
Finviz2026-02-24 21:18:10
Guggenheim Lifts PT on Krystal Biotech (KRYS) to $284 From $224
Finviz2026-02-28 07:24:45
Exclusive-Anthropic investors push to de-escalate Pentagon clash over AI safeguards, sources say
101 finance2026-03-04 17:06:10
Exclusive-Anthropic investors push to de-escalate Pentagon clash over AI safeguards, sources say
101 finance2026-03-04 17:09:42
AI startup Thinking Machines clinches capital and a major chip supply deal from Nvidia
101 finance2026-03-10 13:12:47
AI startup Thinking Machines clinches capital and a major chip supply deal from Nvidia
101 finance2026-03-10 13:15:18

